The impact of semaglutide on cardiac repolarization was tested in a radical QTc demo. Semaglutide would not lengthen QTc intervals at doses as many as 1.5 mg at steady-point out. Some scientific tests advise that even though the incidence of gastrointestinal adverse activities is similar to that of GLP-1 receptor agonists, the twin mechanism of